Your browser doesn't support javascript.
loading
Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes.
Díaz, Luis Antonio; Fuentes-López, Eduardo; Idalsoaga, Francisco; Ayares, Gustavo; Corsi, Oscar; Arnold, Jorge; Cannistra, Macarena; Vio, Danae; Márquez-Lomas, Andrea; Ramirez-Cadiz, Carolina; Medel, María Paz; Hernandez-Tejero, María; Ferreccio, Catterina; Lazo, Mariana; Roblero, Juan Pablo; Cotter, Thomas G; Kulkarni, Anand V; Kim, Won; Brahmania, Mayur; Louvet, Alexandre; Tapper, Elliot B; Dunn, Winston; Simonetto, Douglas; Shah, Vijay H; Kamath, Patrick S; Lazarus, Jeffrey V; Singal, Ashwani K; Bataller, Ramon; Arrese, Marco; Arab, Juan Pablo.
Afiliação
  • Díaz LA; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Observatorio Multicéntrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile.
  • Fuentes-López E; Observatorio Multicéntrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile; Departamento de Ciencias de la Salud, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Idalsoaga F; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Ayares G; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Corsi O; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Arnold J; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Cannistra M; Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Vio D; Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Márquez-Lomas A; Escuela de Medicina, Universidad Anáhuac Mayab, Mérida, Mexico.
  • Ramirez-Cadiz C; Department of Anesthesiology, London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Medel MP; Departamento de Medicina Familiar, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Hernandez-Tejero M; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Ferreccio C; Public Health Department, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Advanced Center for Chronic Diseases, ACCDis, Santiago, Chile.
  • Lazo M; Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA; Urban Health Collaborative, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA; Division of General Internal Medicine, Johns Hopkins
  • Roblero JP; Sección Gastroenterología, Hospital Clínico Universidad de Chile, Escuela de Medicina Universidad de Chile, Santiago, Chile.
  • Cotter TG; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Kulkarni AV; Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India.
  • Kim W; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
  • Brahmania M; Univeristy of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada.
  • Louvet A; Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France.
  • Tapper EB; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA; Gastroenterology Section, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
  • Dunn W; University of Kansas Medical Center, KS, USA.
  • Simonetto D; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Shah VH; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Kamath PS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Lazarus JV; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA; Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Singal AK; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • Bataller R; Liver Unit, Hospital Clinic, Barcelona, Spain.
  • Arrese M; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Observatorio Multicéntrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile.
  • Arab JP; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Observatorio Multicéntrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western Univers
J Hepatol ; 80(3): 409-418, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37992972
BACKGROUND & AIMS: The long-term impact of alcohol-related public health policies (PHPs) on disease burden is unclear. We aimed to assess the association between alcohol-related PHPs and alcohol-related health consequences. METHODS: We conducted an ecological multi-national study including 169 countries. We collected data on alcohol-related PHPs from the WHO Global Information System of Alcohol and Health 2010. Data on alcohol-related health consequences between 2010-2019 were obtained from the Global Burden of Disease database. We classified PHPs into five items, including criteria for low, moderate, and strong PHP establishment. We estimated an alcohol preparedness index (API) using multiple correspondence analysis (0 lowest and 100 highest establishment). We estimated an incidence rate ratio (IRR) for outcomes according to API using adjusted multilevel generalized linear models with a Poisson family distribution. RESULTS: The median API in the 169 countries was 54 [IQR 34.9-76.8]. The API was inversely associated with alcohol use disorder (AUD) prevalence (IRR 0.13; 95% CI 0.03-0.60; p = 0.010), alcohol-associated liver disease (ALD) mortality (IRR 0.14; 95% CI 0.03-0.79; p = 0.025), mortality due to neoplasms (IRR 0.09; 95% CI 0.02-0.40; p = 0.002), alcohol-attributable hepatocellular carcinoma (HCC) (IRR 0.13; 95% CI 0.02-0.65; p = 0.014), and cardiovascular diseases (IRR 0.09; 95% CI 0.02-0.41; p = 0.002). The highest associations were observed in the Americas, Africa, and Europe. These associations became stronger over time, and AUD prevalence was significantly lower after 2 years, while ALD mortality and alcohol-attributable HCC incidence decreased after 4 and 8 years from baseline API assessment, respectively (p <0.05). CONCLUSIONS: The API is a valuable instrument to quantify the robustness of alcohol-related PHP establishment. Lower AUD prevalence and lower mortality related to ALD, neoplasms, alcohol-attributable HCC, and cardiovascular diseases were observed in countries with a higher API. Our results encourage the development and strengthening of alcohol-related policies worldwide. IMPACT AND IMPLICATIONS: We first developed an alcohol preparedness index, an instrument to assess the existence of alcohol-related public policies for each country. We then evaluated the long-term association of the country's alcohol preparedness index in 2010 with the burden of chronic liver disease, hepatocellular carcinoma, other neoplasms, and cardiovascular disease. The strengthening of alcohol-related public health policies could impact long-term mortality rates from cardiovascular disease, neoplasms, and liver disease. These conditions are the main contributors to the global burden of disease related to alcohol use. Over time, this association has not only persisted but also grown stronger. Our results expand the preliminary evidence regarding the importance of public health policies in controlling alcohol-related health consequences.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Carcinoma Hepatocelular / Alcoolismo / Hepatopatias Alcoólicas / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Chile

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Carcinoma Hepatocelular / Alcoolismo / Hepatopatias Alcoólicas / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Chile